These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 37511372)
1. Effect of Allergen-Specific Immunotherapy on Transcriptomic Changes in Canine Atopic Dermatitis. Majewska A; Gajewska M; Dembele K Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511372 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases. Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279 [TBL] [Abstract][Full Text] [Related]
3. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Griffin CE; Hillier A Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398 [TBL] [Abstract][Full Text] [Related]
4. The future of immunotherapy for canine atopic dermatitis: a review. DeBoer DJ Vet Dermatol; 2017 Feb; 28(1):25-e6. PubMed ID: 28133873 [TBL] [Abstract][Full Text] [Related]
5. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis. Plant JD; Neradilek MB BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956 [TBL] [Abstract][Full Text] [Related]
7. A survey of primary care practitioners' referral habits and recommendations of allergen-specific immunotherapy for canine and feline patients with atopic dermatitis. Flanagan S; Schick A; Lewis TP; Chu Tater K; Rishniw M Vet Dermatol; 2021 Apr; 32(2):106-e21. PubMed ID: 33275300 [TBL] [Abstract][Full Text] [Related]
8. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study. Mueller RS; Veir J; Fieseler KV; Dow SW Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107 [TBL] [Abstract][Full Text] [Related]
9. Cytokine and Lymphocyte Profiles in Dogs with Atopic Dermatitis after Allergen-Specific Immunotherapy. Majewska A; Dembele K; Dziendzikowska K; Prostek A; Gajewska M Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891200 [TBL] [Abstract][Full Text] [Related]
10. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy. Colombo S; Hill PB; Shaw DJ; Thoday KL Vet Rec; 2007 Jun; 160(25):861-4. PubMed ID: 17586789 [TBL] [Abstract][Full Text] [Related]
11. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor? Ramió-Lluch L; Brazís P; Ferrer L; Puigdemont A Vet Rec; 2020 Dec; 187(12):493. PubMed ID: 33082241 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis. Kawano K; Mizuno T Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy. Martini F; Rostaher A; Favrot C; Fischer N Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678 [TBL] [Abstract][Full Text] [Related]
14. A pilot study to identify perceived barrier and motivating factors of primary veterinarians in the USA for specialty referral and management of atopic dermatitis with allergen-specific immunotherapy. Flanagan S; Schick A; Lewis TP Vet Dermatol; 2020 Oct; 31(5):371-e98. PubMed ID: 32416025 [TBL] [Abstract][Full Text] [Related]
15. Immunoproteomic characterization of a Dermatophagoides farinae extract used in the treatment of canine atopic dermatitis. Moya R; Carnés J; Sinovas N; Ramió L; Brazis P; Puigdemont A Vet Immunol Immunopathol; 2016 Nov; 180():1-8. PubMed ID: 27692089 [TBL] [Abstract][Full Text] [Related]
16. Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis. Shida M; Kadoya M; Park SJ; Nishifuji K; Momoi Y; Iwasaki T Vet Immunol Immunopathol; 2004 Nov; 102(1-2):19-31. PubMed ID: 15451612 [TBL] [Abstract][Full Text] [Related]
17. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis]. Fischer N; Rostaher A; Favrot C Schweiz Arch Tierheilkd; 2016 Sep; 158(9):646-652. PubMed ID: 27655164 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis. Hobi S; Mueller RS Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(3):167-73. PubMed ID: 24920143 [TBL] [Abstract][Full Text] [Related]
19. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis. Fischer NM; Rostaher A; Favrot C Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789 [TBL] [Abstract][Full Text] [Related]
20. Total IgE and allergen-specific IgE and IgG antibody levels in sera of atopic dermatitis affected and non-affected Labrador- and Golden retrievers. Lauber B; Molitor V; Meury S; Doherr MG; Favrot C; Tengvall K; Bergvall K; Leeb T; Roosje P; Marti E Vet Immunol Immunopathol; 2012 Sep; 149(1-2):112-8. PubMed ID: 22739207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]